APA practice guideline for the treatment of patients with Borderline Personality Disorder.pdf

(549 KB) Pobierz
borderline.insidecover.fm
Practice
Guideline
for the
Treatment of Patients
With Borderline
Personality Disorder
American Psychiatric Association
129108136.005.png 129108136.006.png 129108136.007.png 129108136.008.png
Originally published in October 2001.
A guideline watch, summarizing significant developments in
the scientific literature since publication of this guideline,
may be available in the Psychiatric Practice section
of the APA web site at www.psych.org.
Copyright © 2001 American Psychiatric Association
ALL RIGHTS RESERVED
American Psychiatric Association
1000 Wilson Boulevard
Arlington, VA 22209-3901
www.psych.org
129108136.001.png
WORK GROUP ON BORDERLINE PERSONALITY DISORDER
John M. Oldham, M.D., Chair
Katharine A. Phillips, M.D., Consultant
Glen O. Gabbard, M.D.
Marcia K. Goin, M.D., Ph.D.
John Gunderson, M.D.
Paul Soloff, M.D.
David Spiegel, M.D.
Michael Stone, M.D.
STEERING COMMITTEE ON PRACTICE GUIDELINES
John S. McIntyre, M.D., Chair
Sara C. Charles, M.D., Vice-Chair
Kenneth Altshuler, M.D.
C. Deborah Cross, M.D.
Helen Egger, M.D.
Barry J. Landau, M.D.
Louis Alan Moench, M.D.
Allan Tasman, M.D.
Stuart W. Twemlow, M.D.
Sherwyn Woods, M.D., Ph.D.
Joel Yager, M.D.
CONSULTANTS AND LIAISONS
Paula Clayton, M.D. (Consultant)
Amarendra Das, M.D., Ph.D. (Liaison)
Marcia K. Goin, M.D., Ph.D. (Liaison)
Marion Goldstein, M.D. (Liaison)
Sheila Hafter Gray, M.D. (Consultant)
Margaret T. Lin, M.D. (Liaison)
Herbert Meltzer, M.D. (Consultant)
Grayson Norquist, M.D. (Consultant)
Susan Stabinsky, M.D. (Consultant)
Robert Johnston, M.D. (Area I)
James Nininger, M.D. (Area II)
Roger Peele, M.D. (Area III)
Anthony D’Agostino, M.D. (Area IV)
R. Scott Benson, M.D. (Area V)
Lawrence Lurie, M.D. (Area VI)
R. Dale Walker, M.D. (Area VII)
Michael B. First, M.D., Medical Editor, Quick Reference Guides
STAFF
Rebecca M. Thaler, M.P.H., C.H.E.S., Senior Project Manager
Robert Kunkle, M.A., Project Manager
Althea Simpson, Project Coordinator
Claudia Hart, Director, Department of Quality Improvement and Psychiatric Services
Lloyd I. Sederer, M.D., Director, Division of Clinical Services
129108136.002.png
For Continuing Medical Education credit for APA Practice Guidelines,
visit www.psych.org/cme
To order the 2004 Compendium of Quick Reference Guides to the
APA Practice Guidelines,
visit www.appi.org or call 800-368-5777.
The American Board of Psychiatry and Neurology (ABPN)
has reviewed the APA Practice Guidelines CME Program
and has approved this product as part of a comprehensive
lifelong learning program, which is mandated by the
American Board of Medical Specialties as a necessary
component of maintenance of certification.
ABPN approval is time limited to 3 years for each
individual Practice Guideline CME course.
Refer to APA’s CME web site for ABPN approval status of each course.
129108136.003.png
CONTENTS
STATEMENT OF INTENT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . vii
GUIDE TO USING THIS PRACTICE GUIDELINE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . viii
INTRODUCTION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ix
OVERVIEW OF GUIDELINE DEVELOPMENT PROCESS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . x
PART A: TREATMENT RECOMMENDATIONS FOR PATIENTS WITH
BORDERLINE PERSONALITY DISORDER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
I. EXECUTIVE SUMMARY OF RECOMMENDATIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
A. Coding System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
B. General Considerations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
C. Summary of Recommendations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
II. FORMULATION AND IMPLEMENTATION OF A TREATMENT PLAN . . . . . . . . . . . . . . . . . . . . . . . . . . 6
A. The Initial Assessment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
B. Principles of Psychiatric Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
C. Principles of Treatment Selection. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
D. Specific Treatment Strategies for the Clinical Features of Borderline Personality Disorder. . . . . . . . . . . . 14
III. SPECIAL FEATURES INFLUENCING TREATMENT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
A. Comorbidity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
B. Problematic Substance Use . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
C. Violent Behavior and Antisocial Traits. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
D. Chronic Self-Destructive Behavior . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
E. Childhood Trauma and PTSD. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
F. Dissociative Features . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
G. Psychosocial Stressors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
H. Gender . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
I. Cultural Factors. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
J. Age. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
IV. RISK MANAGEMENT ISSUES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
A. General Considerations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
B. Suicide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
C. Anger, Impulsivity, and Violence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
D. Boundary Violations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
129108136.004.png
Zgłoś jeśli naruszono regulamin